返回："香茅醇对 DMBA 诱导的大鼠乳腺癌的剂量依赖性化学预防作用"。

IF 3.5 4区医学 Q2 CHEMISTRY, MEDICINAL Drug Development Research Pub Date : 2024-08-06 DOI:10.1002/ddr.22238

{"title":"返回：\"香茅醇对 DMBA 诱导的大鼠乳腺癌的剂量依赖性化学预防作用\"。","authors":"","doi":"10.1002/ddr.22238","DOIUrl":null,"url":null,"abstract":"RETRACTION: J. Rajendran, P. Pachaiappan and S. Subramaniyan, “Dose-dependent Chemopreventive Effects of Citronellol in DMBA-Induced Breast Cancer Among Rats,” Drug Development Research 80, no. 6 (2019): 867-876, https://doi.org/10.1002/ddr.21570.The above article, published online on 16 July 2019 in Wiley Online Library (wileyonlinelibrary.com), and a corresponding Corrigendum, published on 10 June 2020 (https://doi.org/10.1002/ddr.21703), has been retracted by agreement between the journal Editor-in-Chief, Steven Fletcher; and Wiley Periodicals, LLC. The retraction has been agreed due to an overlap between images presented in Figure 3a and 3 f. Despite the previously produced Corrigendum, the overlap between Figure 3a and 3 f still remains. The authors were unable to provide a satisfactory explanation or provide an acceptable replacement for Figure 3 f. As a result, the editors have lost confidence in the results and conclusions presented in this study. The authors disagree with the retraction.","PeriodicalId":11291,"journal":{"name":"Drug Development Research","volume":"85 5","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ddr.22238","citationCount":"0","resultStr":"{\"title\":\"RETRACTION: “Dose-dependent Chemopreventive Effects of Citronellol in DMBA-Induced Breast Cancer Among Rats”\",\"authors\":\"\",\"doi\":\"10.1002/ddr.22238\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"RETRACTION: J. Rajendran, P. Pachaiappan and S. Subramaniyan, “Dose-dependent Chemopreventive Effects of Citronellol in DMBA-Induced Breast Cancer Among Rats,” Drug Development Research 80, no. 6 (2019): 867-876, https://doi.org/10.1002/ddr.21570.The above article, published online on 16 July 2019 in Wiley Online Library (wileyonlinelibrary.com), and a corresponding Corrigendum, published on 10 June 2020 (https://doi.org/10.1002/ddr.21703), has been retracted by agreement between the journal Editor-in-Chief, Steven Fletcher; and Wiley Periodicals, LLC. The retraction has been agreed due to an overlap between images presented in Figure 3a and 3 f. Despite the previously produced Corrigendum, the overlap between Figure 3a and 3 f still remains. The authors were unable to provide a satisfactory explanation or provide an acceptable replacement for Figure 3 f. As a result, the editors have lost confidence in the results and conclusions presented in this study. The authors disagree with the retraction.\",\"PeriodicalId\":11291,\"journal\":{\"name\":\"Drug Development Research\",\"volume\":\"85 5\",\"pages\":\"\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2024-08-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ddr.22238\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug Development Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/ddr.22238\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Development Research","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ddr.22238","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}

引用次数: 0

摘要

撤回：J. Rajendran, P. Pachaiappan and S. Subramaniyan, "Dose-dependent Chemopreventive Effects of Citronellol in DMBA-Induced Breast Cancer Among Rats," Drug Development Research 80, no. 6 (2019): 867-876, https://doi.org/10.1002/ddr.21570.上述文章于 2019 年 7 月 16 日在线发表于 Wiley Online Library (wileyonlinelibrary.com)，并于 2020 年 6 月 10 日发表了相应的 Corrigendum (https://doi.org/10.1002/ddr.21703)，经期刊主编 Steven Fletcher 和 Wiley Periodicals, LLC 协议，上述文章已被撤回。同意撤稿的原因是图 3a 和图 3 f 中的图像有重叠。尽管之前已经做了更正，但图 3a 和 3 f 之间的重叠仍然存在。作者无法提供令人满意的解释，也无法提供可接受的图 3 f 替代品。因此，编者对本研究的结果和结论失去了信心。作者不同意撤稿。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

RETRACTION: “Dose-dependent Chemopreventive Effects of Citronellol in DMBA-Induced Breast Cancer Among Rats”

RETRACTION: J. Rajendran, P. Pachaiappan and S. Subramaniyan, “Dose-dependent Chemopreventive Effects of Citronellol in DMBA-Induced Breast Cancer Among Rats,” Drug Development Research 80, no. 6 (2019): 867-876, https://doi.org/10.1002/ddr.21570.

The above article, published online on 16 July 2019 in Wiley Online Library (wileyonlinelibrary.com), and a corresponding Corrigendum, published on 10 June 2020 (https://doi.org/10.1002/ddr.21703), has been retracted by agreement between the journal Editor-in-Chief, Steven Fletcher; and Wiley Periodicals, LLC. The retraction has been agreed due to an overlap between images presented in Figure 3a and 3 f. Despite the previously produced Corrigendum, the overlap between Figure 3a and 3 f still remains. The authors were unable to provide a satisfactory explanation or provide an acceptable replacement for Figure 3 f. As a result, the editors have lost confidence in the results and conclusions presented in this study. The authors disagree with the retraction.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Drug Development Research 医学-药学

CiteScore

6.40

自引率

2.60%

发文量

104

审稿时长

6-12 weeks

期刊介绍： Drug Development Research focuses on research topics related to the discovery and development of new therapeutic entities. The journal publishes original research articles on medicinal chemistry, pharmacology, biotechnology and biopharmaceuticals, toxicology, and drug delivery, formulation, and pharmacokinetics. The journal welcomes manuscripts on new compounds and technologies in all areas focused on human therapeutics, as well as global management, health care policy, and regulatory issues involving the drug discovery and development process. In addition to full-length articles, Drug Development Research publishes Brief Reports on important and timely new research findings, as well as in-depth review articles. The journal also features periodic special thematic issues devoted to specific compound classes, new technologies, and broad aspects of drug discovery and development.